Research institute in the
Canton of Ticino
237 companies in Research institute based in the Canton of Ticino — name and year of registration from the commercial register.
50 of 237 companies
Fondazione per l'istituto di Ricerca in Biomedicina (IRB)
Since 1997 · 21–50 empl.4.7(47)
The company's core activity is research and teaching in the fields of biology, chemistry and related sciences, particularly in the areas of mass spectrometry, microscopy, protein production and animal welfare. The company also provides support services such as IT support, technology transfer, administration and training, including PhD programs, master's and bachelor's theses as well as pre-doctoral training.
Foundation for Cardiological Research and Education - FCRE
Since 2012 · 1–10 empl.4.4(54)
Foundation for Cardiological Research and Education - FCRE supports cardiological research, clinical services and professional training connected with Istituto Cardiocentro Ticino.
NAIE Natural Alternatives International Europe SA
Since 1999 · 21–50 empl.4.3(36)
The core activity of Natural Alternatives International Europe SA (NAIE) is the development, manufacturing and packaging of dietary supplements, particularly custom formulation and contract manufacturing of dietary supplements for the international market. The company also offers services such as quality control, testing and packaging.
SOLS SA
Since 2013 · 1–10 empl.4.5(8)
SOLS SA develops and distributes an innovative regeneration technology called magma13, aimed at improving human well-being and longevity. This technology optimizes the environment to support the body's natural regeneration processes, achieving a range of benefits including improved vitality, better sleep, increased concentration and creativity, as well as anti-aging effects.
Alpex Pharma SA
Since 1983 · 101–500 empl.4.0(3)
The core activity of Alpex is the development and manufacture of pharmaceutical and nutraceutical products, particularly the research, development and production of medicines and dietary supplements. The company offers a wide range of services, including formulation development, clinical trials, product registration, manufacturing and global exports. Alpex focuses on the development of innovative medicines and treatments for various therapeutic areas, such as pain management, arthritis, osteoporosis and rare diseases.
Avyxa GmbH
Since 2004 · 11–20 empl.4.7(3)
The core activity of Ingenus Pharmaceuticals is the development, manufacture and marketing of generic medicines as cost-effective solutions for patients, suppliers and other stakeholders in the healthcare sector.
Fordras SA
Since 1983 · 101–500 empl.
The company's core activity is the development, production and marketing of natural proteins and enzymes for the food, pharmaceutical and feed industries. The company focuses particularly on the production of highly concentrated, active ingredients for industrial applications, such as lysozymes, and offers solutions for food processing and preservation as well as for the health and nutrition industry.
Fondazione per la ricerca sul cancro nel Ticino
Since 1985 · 11–20 empl.
Fondazione per la ricerca sul cancro nel Ticino funds scientific research projects in oncology and awards research scholarships and a prize. The foundation operates in coordination with Lega cancro Ticino, which by statute holds the majority of seats on the foundation board and supports the allocation of grants to researchers domiciled or active in the canton.
Tecnomedia Service Sagl
Since 1994 · 1–10 empl.
Tecnomedia Service Sagl provides technical services across visuals, acoustics, mechanics, electronics and information technology. Services include managed video surveillance (design, installation, operation, maintenance and remote access), webcam hosting and architectural acoustic analysis and remediation.
Osmopharm SA
Since 1994 · 1–10 empl.
The core activity of Osmopharm SA is the development and production of modified oral dosage forms, particularly in pellet, tablet or resin form, using advanced galenic technologies such as coating, extrusion-spheronization and ion exchange. The company also offers services such as the manufacture of hard gelatin capsules or tablets, capsule filling and packaging of pharmaceuticals. Additionally, Osmopharm supports its customers in preparing registration applications and conducting regulatory activities.
Cross Research SA
Since 1997 · 11–20 empl.
The core activity of CROSS Research SA is the conduct of clinical trials, particularly Phase I trials, for the pharmaceutical industry. The company offers services such as central clinical laboratories, analytical laboratories for drug analysis and pharmaceutical laboratories for the development of drugs. It also conducts safety studies, dose-finding studies, bioavailability and bioequivalence studies, as well as specialized studies such as skin adhesion studies and medical device testing.
Sensoptic SA
Since 1998 · 1–10 empl.
The core activity of Sensoptic SA is the development, manufacture and distribution of sensors, cameras, software and other components for optical measurement systems, particularly for industrial applications. The company also offers services such as measurements in customer facilities or in its own laboratory, as well as the development of custom sensors.
CHELONIA SA
Since 2002 · 11–20 empl.
The core activity of Chelonia SA is to support academic spin-offs and start-ups in the development of market-ready products and services. This includes providing strategic consulting, facilitating partnerships, and supporting the acquisition of public and private funding, particularly within the framework of EU programs such as Horizon Europe. Additionally, Chelonia SA offers services such as innovation consulting, R&D acceleration, spin-off incubation, and venture support to promote the development of new technologies and products.
Fondazione Sir John Eccles
Since 2003 · 11–20 empl.
The core activity of the Fondazione Sir John Eccles is to promote scientific and philosophical studies and research in the field of neurobiology, particularly with regard to the relationship between the brain and consciousness. The foundation organizes events, conferences, symposia, and research programs to foster dialogue between scientists, philosophers, and experts from various disciplines. It also supports the publication of research results and the organization of cultural events to inform the public about the latest developments in this field.
NOVELTY PHARMA GALENICAL DEVELOPMENT AND DOCUMENTATION SA
Since 2003 · 11–20 empl.
The core activity of Novelty Pharma is the production of customer-specific, tailor-made effervescent tablets.
ARGOR-ALJBA SA
Since 2004 · 11–20 empl.
The core activity of Argor-Aljba is the development, production and application of nanotechnological coatings, in particular Diamond-Like-Carbon (DLC) coatings, for various industrial and luxury applications, such as tools, watches, jewelry and other high-end products.
physARCH Sagl
Since 2006 · 1–10 empl.
The core activity of phys ARCH sagl consists in the application of physical and mathematical models to architecture, urban planning, territorial planning and the environment. Specifically, this includes: the development of mathematical models for architecture and urban planning; conducting studies and consulting in the field of urban and spatial planning; environmental consulting and planning; research and consulting in the field of museums and archives. The company thus offers interdisciplinary services that touch the interface between physics, mathematics, architecture and the environment.
NANONICA SA
Since 2006 · 1–10 empl.
NANONICA SA facilitates the transfer of knowledge from academia to industry in nanotechnology and microtechnology. It develops and commercializes research results, with applications including medicine, energy and environmental science.
DRM DISASTER RISK MANAGEMENT SWITZERLAND SA
Since 2007 · 1–10 empl.
The core activity of DRM (Disaster Risk Management) is to research, implement and disseminate strategies and methods to reduce disaster risks. This includes in particular: applied research in the field of disaster risk management, development of tools and strategies for risk assessment and reduction, promotion of partnerships with governments, private companies, international organizations and NGOs, provision of information and resources for disaster risk reduction, and support for countries, especially developing countries, in implementing disaster risk management strategies. The company aims to minimize the impact of disasters on human society, the economy and the environment.
Ugo Basile R&D SA
Since 2007 · 1–10 empl.
Ugo Basile R&D SA develops and manufactures scientific instruments and devices for biomedical research. Its product range includes solutions for behavioural testing, pain and inflammation studies, motor coordination, blood pressure, metabolism and feeding, as well as ventilation and anaesthesia applications.
Lallemand Pharma AG
Since 2007 · 11–20 empl.
The core activity of Lallemand Pharma is the development and marketing of respiratory products classified as medicinal products or medical devices. In particular, the company focuses on the manufacture of immunostimulant drugs and medical devices based on bacterial lysates such as PMBL.
CoreQuest Sagl
Since 2008 · 1–10 empl.
CoreQuest Sagl is a pharmaceutical company conducting research and development of pharmaceutical products and medical devices in nephrology and surgical areas. It develops biocompatible hypertonic solutions for peritoneal dialysis, designs devices and monitoring techniques for dialysis patients, and pursues research programs addressing chronic renal failure and congestive heart failure, including a peritoneal ultrafiltration platform (Polycore).
Innocenti SA
Since 2008 · 1–10 empl.
Innocenti SA owns the worldwide trademark rights to Innocenti, Lambretta and Lambro. It develops the three brand lines covering cars, scooters and three-wheel commercial vehicles.
SAPHYRION Sagl
Since 2009 · 11–20 empl.
The core activity of Saphyrion is the development and manufacturing of radiation-hard, space-qualified integrated circuits (ASICs) as well as instruments for the analysis of GNSS data (Global Navigation Satellite System) for use in space exploration.
Swiss Stem Cell Foundation
Since 2009 · 11–20 empl.
The company's core activity is research and development in the field of stem cells, particularly the development of new cell therapies for human medical use. This also includes education, consulting and dissemination of knowledge in this area.
Cosmetic Consulting JW & Partner Sagl
Since 2010 · 1–10 empl.
Cosmetic Consulting JW & Partner Sagl develops and formulates skincare and haircare products, cosmeceuticals and eco-cosmetics. The company provides scientific research, formula development, packaging design, quality assurance, regulatory documentation (safety assessment, product information file) and support with CPNP registration, as well as production coordination and product launch services.
MA R&D Sagl
Since 2010 · 1–10 empl.
The core activity of MA R&D is the development and manufacturing of eyeglasses, particularly pre-assembled eyeglasses, as well as research and innovation of eyeglass lenses, frames and accessories.
Mendes SA
Since 2011 · 1–10 empl.
The core activity of Mendes SA is the scientific development and distribution of innovative probiotic formulations for health and well-being.
Humabs BioMed SA
Since 2011 · 11–20 empl.
The core activity of Humabs BioMed SA is the discovery and development of anti-infective immunotherapies for the treatment of viral and bacterial diseases, including those caused by Zika, Ebola, Rabies, Dengue and other Flaviviruses. The company focuses on the development of therapeutics up to clinical proof of concept and has a broad pipeline of development candidates.
Lab Technologies SA
Since 2013 · 21–50 empl.
The core activity of Smartlis is the development and implementation of innovative laboratory information systems (LIS) for healthcare institutions. The company focuses on creating software solutions that improve clinical diagnosis and patient care. Smartlis' systems are designed to manage laboratory networks, integrate with healthcare information systems, and meet the needs of laboratories that are distinguished by their size, multicentricity, and internationality.
3B Biotech Research SAGL
Since 2013 · 11–20 empl.
The core activity of 3B Biotech is to provide services as a contract research organization (CRO) for the pharmaceutical, biotechnological, medical and food industries. This includes in particular: Clinical trials and studies, Observational and late-phase studies, Regulatory affairs, Pharmacovigilance, Services for medical devices, and Application of artificial intelligence in research and development. The company supports its customers in the development, research and marketing of products and offers customized solutions and services.
LasiGroup EMS SA
Since 2013 · 1–10 empl.
LasiGroup EMS SA provides Electronic Manufacturing Services (EMS), including design, prototyping and volume production of printed circuit boards and electronic systems. Its services also cover industrial automation, trading, supply‑chain and post‑sales support, and an integrated quality management system compliant with ISO 9001, IATF 16949, ISO 14001 and ISO 45001.
DAC System SA
Since 2013 · 11–20 empl.
The core activity of DAC System is the development and manufacture of solutions for monitoring and controlling radio transmission systems, particularly in the field of broadcasting and critical communication. The company offers specialized products and services to improve the reliability and efficiency of radio transmission systems, including solutions for monitoring antennas, power measurement and predictive maintenance.
ARXÉ Sagl
Since 2015 · 1–10 empl.
ARXÉ Sagl develops and distributes Hydrogel H42, a collagen-based resorbable gel for the treatment of periodontal and peri-implant pockets. The company states the product is antibiotic-free and provides clinical information and support for dental professionals.
CEBIS INTERNATIONAL SAGL
Since 2016 · 11–20 empl.
The core activity of CEBIS is the conduct of clinical trials and the provision of regulatory services for the pharmaceutical industry, biotechnology companies, and manufacturers of medical devices. This includes, among other things: Conduct of clinical trials (Phase II-IV), regulatory support for market authorization, management of clinical trials, creation of regulatory documents (e.g. CTD for medicinal products), conduct of disease registries, and regulatory affairs and compliance services. CEBIS positions itself as a full-service provider for clinical research and regulatory services, offering its customers a comprehensive range of services to support their products from idea to market authorization.
Finarmodule Sagl
Since 2016 · 1–10 empl.
The core activity of Finar Module is the development and manufacture of innovative packaging solutions for power electronics and LEDs, with a particular focus on overcoming thermomechanical limitations through the development of CTE-compliant buffers.
BeeHelpful SA
Since 2017 · 1–10 empl.
BeeHelpful SA develops and sells the Primal Bee thermodynamically engineered beehives and related beekeeping products. The company manufactures insulated hive kits and accessories (made from 100% recyclable EPS), provides technical documentation and field-tested research, and sells directly via its online store.
GT Gain Therapeutics SA
Since 2017 · 11–20 empl.
The company is active in the field of biopharmaceuticals (bio-pharma).
Blockchain District SA
Since 2018 · 11–20 empl.
The core activity of B-District is to provide consulting and research and development (R&D) services to companies to increase their innovation rates and create long-term value. This includes, among other things: strategy consulting (Corporate Strategy, Business Strategy, Finance Function Strategy), innovation management (Innovation Park, Stardome), research and development (R&D), and consulting on the development of business models and strategies. The company positions itself as the 'Architects of Innovation' and supports companies in overcoming their greatest challenges and leveraging their greatest innovation opportunities.
START Insight Sagl
Since 2018 · 1–10 empl.
START Insight Sagl is a research and consulting organisation producing analysis and studies on defence, security, terrorism and radicalisation. It offers research and analysis, editorial production including radio and TV reports and documentaries, network and consortium building, event organisation, teaching and consulting services.
MV BioTherapeutics SA
Since 2018 · 11–20 empl.
The core activity of MV BioTherapeutics SA is the development and application of technologies for regulating the intestinal ecosystem in medical applications, particularly through the ApyraMed/ApyraVax platform. This platform enables the conditional regulation of the intestinal ecosystem to control the adaptive immune response and promote mutualism with intestinal commensals. The company focuses on developing solutions for medical applications, particularly in the fields of mucosal immunology and biomedicine.
Newtron Group SA
Since 2019 · 1–10 empl.
Newtron Group SA develops solutions for vehicle hybridisation and electrification and provides engineering, specialised consulting, prototyping and homologation services. The company operates in sustainable mobility and supports projects from development through approval.
Officine Fioravanti SA
Since 2019 · 1–10 empl.
Officine Fioravanti SA is engaged in the development and implementation of special vehicle conversions and modifications, particularly in the field of classic and vintage cars (Hyperclassic, Sportclassic), as well as in the development of technical solutions and innovations (Evoluzioni Tecniche) for the automotive industry.
Xegate SA
Since 2020 · 1–10 empl.
Xegate SA is a private incubator and technology company providing research & development, technology transfer, incubation, and prototyping services for startups and companies. It operates dedicated units for research selection, business development and fundraising, facilities management, and engineering, and offers services in IP, commercialization, training and technical consultancy.
O3ZY SA
Since 2020 · 1–10 empl.
O3ZY SA provides systems for analysing, monitoring and sanitising indoor environments, as well as devices for treating air and surfaces. Its product range includes OZY AIR, which uses ozone technology, and OZY LIGHT, which uses UV-C technology.
Bios plus
Since 2021 · 21–50 empl.
The core activity of Bios⁺ is to promote, support and coordinate scientific research and teaching in the field of life sciences. The goal is to create a national and international research center for life sciences in Bellinzona, Switzerland.
bioethica food safety engineering sagl
Since 1992 · 1–10 empl.
Escort Cold Chain Solutions SA
Since 2007 · 1–10 empl.
Giacomatica Sagl
Since 2015 · 1–10 empl.
Giacomatica Sagl is a company with a contact page on its website, but the accessed page did not provide sufficient information about its services or core business activities.
WORTHEL AG
Since 2017 · 1–10 empl.
Research institute in the Canton of Ticino
Research institute in the region
Point size by number of companies per place.
Source: commercial register (Zefix) · as of November 5, 2026
Research institute in other places
By canton